Obesity in Patients with COVID-19

Obesity raises the likelihood of hospitalisation, ICU admission, IMV therapy, and death in COVID-19 patients. Furthermore, excessive visceral adiposity appears to be connected to poor COVID-19 outcomes. These findings highlight the importance of individuals, the general public, and governments taking effective measures to raise awareness of the hazards associated with obesity and how they are exacerbated in the current worldwide epidemic. Obesity is frequent among coronavirus patients in 2019 (COVID-19). Obesity's impact on COVID-19 clinical outcomes warrants further investigation.

  • Coronavirus disease 2019
  • Intensive care
  • Mortality
  • Obesity
  • Visceral adipose tissue

Related Conference of Obesity in Patients with COVID-19

March 27-28, 2024

10th International Conference on Gynecology and Obstetrics

Amsterdam, Netherlands
April 11-12, 2024

7th International Conference on Obesity and Chronic Diseases

Amsterdam, Netherlands
June 10-11, 2024

24th Global Summit on Obesity

Dubai, UAE
June 27-28, 2024

20th Euro Obesity and Endocrinology Congress

London, UK
August 29-30, 2024

18th International Conference on Obesity Medicine

Helsinki, Finland

Obesity in Patients with COVID-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in